Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation

Cell and Tissue Research

Volumn 292, Issue 2, 1998, Pages 333-343

  Qu, Rong ^a,b   Silver, Meredith M ^a   Letarte, Michelle ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Heart; Human; TGF ; TGF receptors; Vascular disorders; Vascular endothelium

Indexed keywords

ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; EMBRYO; ENDOCARDIUM; ENDOTHELIUM CELL; HEART DEVELOPMENT; HEART VALVE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MESENCHYME; NEWBORN; PRIORITY JOURNAL;

ACTIVIN RECEPTORS, TYPE I; ANTIGENS, CD; BLOTTING, WESTERN; EMBRYONIC AND FETAL DEVELOPMENT; ENDOCARDIUM; ENDOTHELIUM, VASCULAR; HEART VALVES; HUMANS; IMMUNOENZYME TECHNIQUES; MESODERM; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TISSUE DISTRIBUTION; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031981468     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004410051064     Document Type: Article

References (53)

1. Akhurst RJ, Lehnen SA, Faissner AJ, Duffie E (1990) TGF-beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108:645-656
2. Akhurst RJ, Fitzpatrick DR, Fowlis DJ, Gatherer D, Millan FA, Slager H (1992) The role of TGF-βs in mammalian development and neoplasia. Mol Reprod Dev 3:127-135
3. Akhurst RJ, Dickson M, Millan FA (1994) Transforming growth factor-βs and cardiac development. In: Cummins P (ed) Growth factors and the cardiovascular system. Kluwer Academic, Boston, pp 347-366
4. Baldwin HS, Shen HM, Yan H-C, DeLisser HM, Chung A, Mickanin C, Trask T, Kirschbaum NE, Newman PJ, Abelda SM, Buck CA (1994) Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31); alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120:2539-2553
5. Barnett JV, Moustakas A, Lin W, Wang X-F, Lin HY, Galper JB, Maas RL (1994) Cloning and developmental expression of the chick type II and type III TGFβ receptors. Dev Dyn 199:12-27
6. Bottner M, Unsicker K, Suter-Crazzolara C (1996) Expression of TGF-β type II receptor mRNA in the CNS. Mol Neurosci 7: 2903-2907
7. Braverman IM, Keh A, Jacobson BS (1990) Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 95:422-427
8. Brown CB, Boyer AS, Runyan RB, Barnett JV (1996) Antibodies to the type II TGF-β receptor block cell activation and migration during atrioventricular cushion transformation in the heart. Dev Biol 174:248-257
9. Cabanas C, Sanchez-Madrid F, Bellon T, Figdor CG, Te Velde AA, Fernandez JM, Acevedo A, Bernabeu C (1989) Characterization of a novel myeloid antigen regulated during differentiation of monocytic cells. Eur J Immunol 19:1373-1378
10. Cheifetz S, Bellón T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M (1992) Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 267:19027-19030
11. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
12. DeLisser HM, Newman PJ, Albelda SM (1994) Molecular and functional aspects of PECAM-1/CD31. Immunol Today 15:490-495
13. Dickson MC, Slager HG, Duffie E, Mummery CL, Akhurst RJ (1993) RNA and protein localisations of TGFβ2 in the early mouse embryo suggest an involvement in cardiac development. Development 117:625-639
14. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 121:1845-1854
15. Folkman J, D'Amore PA (1996) Blood vessel formation: what is its molecular basis? Cell 87:1153-1155
16. Gatherer D, Ten Dijke P, Baird DT, Akhurst RJ (1990) Expression of TGFβ isoforms during first trimester human embryogenesis. Development 110:445-460
17. Gougos A, Letarte M (1988) Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 141:1925-1933
18. Gougos A, Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265:8361-8364
19. Guttmacher AE, Marchuk DA, White RIJ (1995) Hereditary hemorrhagic telangiectasia. N Eng J Med 333:918-924
20. Hanahan D (1997) Signaling vascular morphogenesis. Science 277: 48-50
21. Jindal SK, Snoey DM, Lobb DK, Dorrington JH (1994) Transforming growth factor α localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol Oncol 53:17-23
22. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Lopez LA, Langa C, Fabra A, Letarte M, Bernabeu C (1996) Endoglin modulates cellular responses to TGF-β1. J Cell Biol 133: 1109-1121
23. Lawler S, Candia AF, Ebner R, Shum L, Lopez AR, Moses HL, Wright CVE, Derynck R (1994) The murine type II TGF-β receptor has a coincident embryonic expression and binding preference for TGF-β1. Development 120:165-175
24. Letarte M, Greaves A, Vera S (1995) CD105 (endoglin) cluster report. In: Schlossman SF et al (eds) Leukocyte typing V. White cell differentiation antigens. Oxford University Press, Oxford, pp 1756-1759
25. López-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massagué J (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor. Cell 67:785-795
26. López-Casillas F, Wrana JL, Massagué J (1993) Betaglycan presents ligand to the TGF-β receptor. Cell 73:1435-1444
27. López-Casillas F, Payne HM, Andres JL, Massagué J (1994) Betaglycan can act as a dual modulator of TGF-β access to signaling receptors: mapping of ligand binding and GAG attachement sites. J Cell Biol 124:557-568
28. Macìas-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL (1996) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signalling. Cell 87:1215-1224
29. Madri JA, Kocher O, Merwin JR, Bell L, Tucker A, Basson CT (1990) Interactions of vascular cells with transforminig growth factors-β. Ann NY Acad Sci 243-258
30. Massagué J, Attisano L, Wrana JL (1994) The TGF-β family and its composite receptors. Trends Cell Biol 4:172-178
31. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, McCormick MK, Pericak-Vance MA, Heutink P, Oostra BA, Haitjema T, Westerman CJJ, Porteus ME, Guttmacher AE, Letarte M, Marchuk DA (1994) Endoglin, a TGF-β binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genet 8:345-351
32. McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteus ME, Guttmacher AE, Marchuk DA (1995) Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 4:1983-1985
33. Millan FA, Denhez F, Kondaiah P, Akhurst RJ (1991) Embryonic gene expression patterns of TGF β1, β 2 and β3 suggest different developmental functions in vivo. Development 111:131-144
34. Moore KL, Persaud TVN, Shiota K (1994) Color atlas of clinical embryology. Saunders, Philadelphia
35. Newman PJ, Berndt MC, Gorsky J, White GC, Paddock LS, Muller WA (1990) PECAM-1 (CD31): cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 249:1219-1223
36. Oshima M, Oshima H, Taketo MM (1996) TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 179:297-302
37. Pece N, Vera S, Cymerman U, White RIJ, Wrana JL, Letarte M (1997) Mutant endoglin in hereditary hemorrhagic telangiectasia type I is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 100:2568-2579
38. Pelton RW, Dickinson ME, Moses HL, Hogan BLM (1990) In situ hybridization analysis of TGFβ3 expression during mouse development: comparative studies with TGFβ1 and β2. Development 110:609-620
39. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI (1991) Immunohistochemical localisation of TGFβ1, TGFβ2 and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105
40. Pepper MS, Vassalli J-D, Orci L, Montesano R (1993) Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp Cell Res 204:356-363
41. Pichuantes S, Vera S, Bourdeau A, Pece N, Kumar S, Wayner EA, Letarte M (1997) Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens 50:265-276
42. Potts JD, Dagle JM, Walder JA, Weeks DL, Runyan RB (1991) Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligonucleotide to transforming growth factor β3. Proc Natl Acad Sci USA 88: 1516-1520
43. Quackenbush EJ, Letarte M (1985) Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J Immunol 134:1276-1285
44. Quackenbush EJ, Gougos A, Baumal R, Letarte M (1986) Differential localization within human kidney of five membrane proteins expressed on acute lymphoblastic leukemia cells. J Immunol 136:118-124
45. Roelen BAJ, Lin HY, Knezevic V, Freund E, Mummery CL (1994) Expression of TGF-βs and their receptors during implantation and organogenesis of the mouse embryo. Dev Biol 166:716-728
46. Runyan RB, Potts JD, Weeks DL (1992) TGF-β3-mediated tissue interaction during embryonic heart development. Mol Reprod Dev 32:152-159
47. Shovlin CL, Hughes JMB, Scott J, Seidman CE, Seidman JG (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61:68-79
48. St-Jacques S, Forte M, Lye SJ, Letarte M (1994) Localization of endoglin, a transforming growth factor-β binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 51:405-413
49. Wang X-F, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA (1991) Expression cloning and characterization of the TGF-β type III receptor. Cell 67:797-805
50. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanisms of activation of the TGF-β receptor. Nature 370: 341-347
51. Yamaguchi H, Azuma H, Shigekiyo T, Inoue H (1997) A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia. Thromb Haemost 77:243-247
52. Yamashita H, Ichijo H, Grimsby S, Morén A, ten Dijke P, Miyazono K (1994) Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J Biol Chem 269:1995-2001
53. Zhang HW, Shaw ARE, Mak A, Letarte M (1996) Endoglin is a component of the TGF-β receptor complex of human pre-B leukemic cells. J Immunol 156:565-573